Literature DB >> 23908680

Modular microfluidic system as a model of cystic fibrosis airways.

M Skolimowski1, M Weiss Nielsen, F Abeille, P Skafte-Pedersen, D Sabourin, A Fercher, D Papkovsky, S Molin, R Taboryski, C Sternberg, M Dufva, O Geschke, J Emnéus.   

Abstract

A modular microfluidic airways model system that can simulate the changes in oxygen tension in different compartments of the cystic fibrosis (CF) airways was designed, developed, and tested. The fully reconfigurable system composed of modules with different functionalities: multichannel peristaltic pumps, bubble traps, gas exchange chip, and cell culture chambers. We have successfully applied this system for studying the antibiotic therapy of Pseudomonas aeruginosa, the bacteria mainly responsible for morbidity and mortality in cystic fibrosis, in different oxygen environments. Furthermore, we have mimicked the bacterial reinoculation of the aerobic compartments (lower respiratory tract) from the anaerobic compartments (cystic fibrosis sinuses) following an antibiotic treatment. This effect is hypothesised as the one on the main reasons for recurrent lung infections in cystic fibrosis patients.

Entities:  

Year:  2012        PMID: 23908680      PMCID: PMC3423306          DOI: 10.1063/1.4742911

Source DB:  PubMed          Journal:  Biomicrofluidics        ISSN: 1932-1058            Impact factor:   2.800


  74 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  Genetic recombination in Pseudomonas aeruginosa.

Authors:  B W HOLLOWAY
Journal:  J Gen Microbiol       Date:  1955-12

Review 3.  Cells on chips.

Authors:  Jamil El-Ali; Peter K Sorger; Klavs F Jensen
Journal:  Nature       Date:  2006-07-27       Impact factor: 49.962

4.  In vitro analysis of a hepatic device with intrinsic microvascular-based channels.

Authors:  Amedeo Carraro; Wen-Ming Hsu; Katherine M Kulig; Wing S Cheung; Mark L Miller; Eli J Weinberg; Eric F Swart; Mohammad Kaazempur-Mofrad; Jeffrey T Borenstein; Joseph P Vacanti; Craig Neville
Journal:  Biomed Microdevices       Date:  2008-12       Impact factor: 2.838

5.  Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.

Authors:  Sang Sun Yoon; Robert F Hennigan; George M Hilliard; Urs A Ochsner; Kislay Parvatiyar; Moneesha C Kamani; Holly L Allen; Teresa R DeKievit; Paul R Gardner; Ute Schwab; John J Rowe; Barbara H Iglewski; Timothy R McDermott; Ronald P Mason; Daniel J Wozniak; Robert E W Hancock; Matthew R Parsek; Terry L Noah; Richard C Boucher; Daniel J Hassett
Journal:  Dev Cell       Date:  2002-10       Impact factor: 12.270

Review 6.  Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.

Authors:  P K Stotland; D Radzioch; M M Stevenson
Journal:  Pediatr Pulmonol       Date:  2000-11

7.  Pulmonary cellular response to chronic irritation and chronic Pseudomonas aeruginosa pneumonia in cats.

Authors:  M J Thomassen; J D Klinger; G B Winnie; R E Wood; C Burtner; J F Tomashefski; J G Horowitz; B Tandler
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Analysis of intracellular oxygen and metabolic responses of mammalian cells by time-resolved fluorometry.

Authors:  Tomas C O'Riordan; Alexander V Zhdanov; Gelii V Ponomarev; Dmitri B Papkovsky
Journal:  Anal Chem       Date:  2007-11-15       Impact factor: 6.986

9.  Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.

Authors:  J E Pennington; W F Hickey; L L Blackwood; M A Arnaut
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

10.  A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia.

Authors:  J R Starke; M S Edwards; C Langston; C J Baker
Journal:  Pediatr Res       Date:  1987-12       Impact factor: 3.756

View more
  6 in total

1.  Engineered myocardium model to study the roles of HIF-1α and HIF1A-AS1 in paracrine-only signaling under pathological level oxidative stress.

Authors:  Aylin Acun; Pinar Zorlutuna
Journal:  Acta Biomater       Date:  2017-06-16       Impact factor: 8.947

2.  Oral mucosa-on-a-chip to assess layer-specific responses to bacteria and dental materials.

Authors:  Christopher Rahimi; Benjamin Rahimi; Dominic Padova; Seyed A Rooholghodos; Diane R Bienek; Xiaolong Luo; Gili Kaufman; Christopher B Raub
Journal:  Biomicrofluidics       Date:  2018-09-26       Impact factor: 2.800

3.  Human iPSC-derived myocardium-on-chip with capillary-like flow for personalized medicine.

Authors:  Bradley W Ellis; Aylin Acun; U Isik Can; Pinar Zorlutuna
Journal:  Biomicrofluidics       Date:  2017-03-16       Impact factor: 2.800

Review 4.  Myocardial infarction from a tissue engineering and regenerative medicine point of view: A comprehensive review on models and treatments.

Authors:  Gozde Basara; Gokhan Bahcecioglu; S Gulberk Ozcebe; Bradley W Ellis; George Ronan; Pinar Zorlutuna
Journal:  Biophys Rev (Melville)       Date:  2022-08-30

5.  Designing Biomaterial Platforms for Cardiac Tissue and Disease Modeling.

Authors:  Andrew House; Iren Atalla; Eun Jung Lee; Murat Guvendiren
Journal:  Adv Nanobiomed Res       Date:  2020-10-16

Review 6.  Air Quality Effects on Human Health and Approaches for Its Assessment through Microfluidic Chips.

Authors:  Frank Schulze; Xinghua Gao; Darius Virzonis; Samar Damiati; Marlon R Schneider; Rimantas Kodzius
Journal:  Genes (Basel)       Date:  2017-09-27       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.